MedTrace Logo

The All-comers Sirolimus-coated Balloon European Registry

NCT03085823 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2123

Last updated 2024-07-31

No results posted yet for this study

Summary

The purpose of this study is to observe and evaluate the performance of a Sirolimus-eluting Drug Coated Balloon for the treatment of any type of coronary lesions, including native vessel disease and in stent restenosis.

Conditions

  • Percutaneous Coronary Intervention
  • Angioplasty, Balloon, Coronary
  • Coronary Angioplasty, Transluminal Balloon
  • Arteriosclerosis, Coronary

Interventions

DEVICE

Sirolimus Coated Balloon

Sponsors & Collaborators

  • Fatebenefratelli and Ophthalmic Hospital

    lead OTHER

Principal Investigators

  • Bernardo Cortese · Clinica San Carlo, Paderno Dugnano, MI, Italy

  • Antonio Colombo · Humanitas Research Hospital, Rozzano, MI, Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-12-31
Completion
2022-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03085823 on ClinicalTrials.gov